Q4 2025 Holdings
Filed 2026-02-13 | 11 holdings | $4.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Gold TR(GLD) | GOLD SHS | 78463V107 | $2.8M | 6,964 | 64.5% |
| Berkshire Hathaway Inc del(BRK/B) | CL B NEW | 084670702 | $356.8K | 710 | 8.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $292.2K | 8,919 | 6.8% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $210.1K | 15,688 | 4.9% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $176.5K | 18,773 | 4.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $158.4K | 29,495 | 3.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $138.5K | 13,943 | 3.2% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $62.2K | 15,557 | 1.5% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $58.3K | 28,453 | 1.4% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $39.4K | 10,527 | 0.9% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $27.1K | 18,403 | 0.6% |